BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2856216)

  • 1. Serological studies against herpes simplex virus types I & II in cervical carcinoma patients.
    Rajeswari N; Thyagarajan SP; Kanaklata ; Rajendran P; Subramanian S; Vaideeswaran ; Shanta V
    Indian J Pathol Microbiol; 1987 Apr; 30(2):157-62. PubMed ID: 2856216
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes simplex virus and human papilloma virus in the development of cervical carcinoma.
    Kaufman RH; Adam E
    Clin Obstet Gynecol; 1986 Sep; 29(3):678-92. PubMed ID: 3019599
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex type 2 and cervical cancer: immunological and in situ hybridization studies.
    Simard R; Kessous A; Mansour M; Camonis J; Rawls WE
    Prog Clin Biol Res; 1983; 132D():461-9. PubMed ID: 6314363
    [No Abstract]   [Full Text] [Related]  

  • 5. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
    Adam E; Sharma SD; Zeigler O; Iwamoto K; Melnick JL; Levy AH; Rawls WE
    J Natl Cancer Inst; 1972 Jan; 48(1):65-72. PubMed ID: 4347030
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 7. [Herpes simplex virus type 2 and cervix cancer].
    te Velde ER; The TH
    Ned Tijdschr Geneeskd; 1978 Aug; 122(33):1226-30. PubMed ID: 209356
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
    Heise ER; Kucera LS; Raben M; Homesley H
    Cancer Res; 1979 Oct; 39(10):4022-6. PubMed ID: 225014
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serotypes of herpes simplex virus and their association with cervical cancer].
    Kamalian LA; Makhmurian TD; Movsesian EA; Nadzharian NU; Gevorkian VI
    Vopr Onkol; 1980; 26(11):74-8. PubMed ID: 6256973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based seroepidemiological study of cervical cancer.
    Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
    Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
    Najem SN; Vestergaard BF; Potter CW
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to herpes simplex virus (types 1 and 2) in Jamaican patients with cervical dysplasia and neoplasia.
    Prabhakar P; Rao BN; Hosang R; Narla VR; Persaud V
    West Indian Med J; 1984 Jun; 33(2):63-7. PubMed ID: 6091343
    [No Abstract]   [Full Text] [Related]  

  • 13. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 14. Virological and serological studies in pregnancy, in women with suspect genital herpes simplex virus or perinatal cytomegalovirus infections, and in women with carcinoma of the cervix.
    Frenkel LD; Crawford MA; Bellanti JA
    IARC Sci Publ (1971); 1978; (24 Pt 2):911-5. PubMed ID: 221413
    [No Abstract]   [Full Text] [Related]  

  • 15. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
    Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
    Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
    Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
    Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
    Suárez M; Del Campo G; Ojeda JM
    Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Another view of Herpes Simplex Virus type 2.
    Rotkin ID
    JAMA; 1976 May; 235(20):2188-9. PubMed ID: 178936
    [No Abstract]   [Full Text] [Related]  

  • 19. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
    Gilman SC; Docherty JJ; Clarke A; Rawls WE
    Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.